LadRx Corp (LADXD)

[mr10001]

Get ready to RUN

Very interesting news.
From the P.R.
CytRx President and CEO Steven A. Kriegsman, stated, “We believe bafetinib is a cutting-edge treatment that could be efficacious in a wide range of hematological cancers. Our objective is to evaluate results from this trial, and if successful, quickly progress into later-stage clinical trials either internally or with partners. An effective treatment could result in a multi-billion dollar oncology product for CytRx.”

http://finance.yahoo.com/news/CytRx-to-Conduct-Phase-2-bw-3616590555.html?x=0&.v=1

The news should get this stock up over $2.00 this week.